Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration

ACS Nano

Volumn 6, Issue 5, 2012, Pages 4147-4156

  Kapralov, Alexander A ^a   Feng, Wei Hong ^a   Amoscato, Andrew A ^a   Yanamala, Naveena ^a   Balasubramanian, Krishnakumar ^a   Winnica, Daniel E ^a   Kisin, Elena R ^b   Kotchey, Gregg P ^a   Gou, Pingping ^a   Sparvero, Louis J ^a   Ray, Prabir ^c   Mallampalli, Rama K ^c   Klein Seetharaman, Judith ^c   Fadeel, Bengt ^d   Star, Alexander ^a   Shvedova, Anna A ^b   Kagan, Valerian E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Carbon nanotubes; Macrophages; Surfactant

Indexed keywords

ANIMAL MODEL; AQUEOUS PHASE; BRONCHOALVEOLAR LAVAGE FLUID; HYDROPHOBIC ALKYL CHAIN; IN-VITRO; IN-VIVO; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LUNG CELLS; MOLECULAR SPECIATION; MOUSE LUNG; MOUSE MODELS; PHOSPHATIDYL CHOLINE; PHOSPHATIDYLGLYCEROLS; PHOSPHOLIPID BINDING; POLAR HEADGROUPS; PULMONARY SURFACTANTS; STRUCTURAL ASSESSMENTS; SURFACTANT COATING; SURFACTANT PROTEINS;

ADSORPTION; ATOMIC FORCE MICROSCOPY; BIOLOGICAL ORGANS; CARBON NANOTUBES; COATINGS; LIQUID CHROMATOGRAPHY; MACROPHAGES; MAMMALS; MASS SPECTROMETRY; NANOPARTICLES; SINGLE-WALLED CARBON NANOTUBES (SWCN); SURFACE ACTIVE AGENTS;

PHOSPHOLIPIDS;

CARBON NANOTUBE; LIPID; SURFACTANT;

ACID ASPIRATION; ADSORPTION; ANIMAL; ARTICLE; CHEMISTRY; LUNG; METABOLISM; MOUSE; PHARYNX;

ADSORPTION; ANIMALS; LIPIDS; LUNG; MICE; NANOTUBES, CARBON; PHARYNX; RESPIRATORY ASPIRATION; SURFACE-ACTIVE AGENTS;

EID: 84863766513     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn300626q     Document Type: Article

References (48)

1. Schleh, C.; Rothen-Rutishauser, B.; Kreyling, W. G. The Influence of Pulmonary Surfactant on Nanoparticulate Drug Delivery Systems. Eur. J. Pharm. Biopharm. 2011, 77, 350-352.
2. Choi, H. S.; Ashitate, Y.; Lee, J. H.; Kim, S. H.; Matsui, A.; Insin, N.; Bawendi, M. G.; Semmler-Behnke, M.; Frangioni, J. V.; Tsuda, A. Rapid Translocation of Nanoparticles from the Lung Airspaces to the Body. Nat. Biotechnol. 2010, 28, 1300-1303.
3. Chroneos, Z. C.; Sever-Chroneos, Z.; Shepherd, V. L. Pulmonary Surfactant: An Immunological Perspective. Cell. Physiol. Biochem. 2009, 25, 13-26.
4. Hermans, C.; Bernard, A. Lung Epithelium-Specific Proteins: Characteristics and Potential Applications as Markers. Am. J. Respir. Crit. Care Med. 1999, 159, 646-678.
5. Gasser, M.; Rothen-Rutishauser, B.; Krug, H. F.; Gehr, P.; Nelle, M.; Yan, B.; Wick, P. The Adsorption of Biomolecules to Multi-Walled Carbon Nanotubes Is Influenced by Both Pulmonary Surfactant Lipids and Surface Chemistry. J. Nanobiotechnol. 2010, 31.
6. Cedervall, T.; Lynch, I.; Lindman, S.; Berggard, T.; Thulin, E.; Nilsson, H.; Dawson, K. A.; Linse, S. Understanding the Nanoparticle-Protein Corona Using Methods To Quantify Exchange Rates and Affinities of Proteins for Nanoparticles. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 2050-2055.
7. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle Size and Surface Properties Determine the Protein Corona with Possible Implications for Biological Impacts. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 14265-14270.
8. Zhang, H.; Burnum, K. E.; Luna, M. L.; Petritis, B. O.; Kim, J. S.; Qian, W. J.; Moore, R. J.; Heredia-Langner, A.; Webb-Robertson, B. J.; Thrall, B. D.; et al. Quantitative Proteomics Analysis of Adsorbed Plasma Proteins Classifies Nanoparticles with Different Surface Properties and Size. Proteomics 2011, 11, 4569-4577.
9. Dutta, D.; Sundaram, S. K.; Teeguarden, J. G.; Riley, B. J.; Fifield, L. S.; Jacobs, J. M.; Addleman, S. R.; Kaysen, G. A.; Moudgil, B. M.; Weber, T. J. Adsorbed Proteins Influence the Biological Activity and Molecular Targeting of Nanomaterials. Toxicol. Sci. 2007, 100, 303-315.
10. Ehrenberg, M. S.; Friedman, A. E.; Finkelstein, J. N.; Oberdorster, G.; McGrath, J. L. The Influence of Protein Adsorption on Nanoparticle Association with Cultured Endothelial Cells. Biomaterials 2009, 30, 603-610.
11. Ge, C.; Du, J.; Zhao, L.; Wang, L.; Liu, Y.; Li, D.; Yang, Y.; Zhou, R.; Zhao, Y.; Chai, Z.; et al. Binding of Blood Proteins to Carbon Nanotubes Reduces Cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 16968-16973.
12. Konduru, N. V.; Tyurina, Y. Y.; Feng, W.; Basova, L. V.; Belikova, N. A.; Bayir, H.; Clark, K.; Rubin, M.; Stolz, D.; Vallhov, H.; et al. Phosphatidylserine Targets Single-Walled Carbon Nanotubes to Professional Phagocytes in Vitro and in Vivo. PLoS One 2009, 4, e4398.
13. Dunkelberger, J. R.; Song, W. C. Complement and Its Role in Innate and Adaptive Immune Responses. Cell Res. 2010, 20, 34-50.
14. Hellstrand, E.; Lynch, I.; Andersson, A.; Drakenberg, T.; Dahlback, B.; Dawson, K. A.; Linse, S.; Cedervall, T. Complete High-Density Lipoproteins in Nanoparticle Corona. FEBS J. 2009, 276, 3372-3381.
15. Veldhuizen, R.; Nag, K.; Orgeig, S.; Possmayer, F. The Role of Lipids in Pulmonary Surfactant. Biochim. Biophys. Acta 1998, 1408, 90-108.
16. Guthmann, F.; Haupt, R.; Schlame, M.; Stevens, P. A.; Rustow, B. Alveolar Surfactant Subfractions Differ in Their Lipid Composition. Int. J. Biochem. Cell Biol. 1995, 27, 1021-1026.
17. Numata, M.; Chu, H. W.; Dakhama, A.; Voelker, D. R. Pulmonary Surfactant Phosphatidylglycerol Inhibits Respiratory Syncytial Virus-Induced Inflammation and Infection. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 320-325.
18. Hallman, M.; Gluck, L. Phosphatidylglycerol in Lung Surfactant. III. Possible Modifier of Surfactant Function. J. Lipid Res. 1976, 17, 257-262.
19. Tyurina, Y. Y.; Tyurin, V. A.; Kaynar, A. M.; Kapralova, V. I.; Wasserloos, K.; Li, J.; Mosher, M.; Wright, L.; Wipf, P.; Watkins, S.; Pitt, B. R.; et al. Oxidative Lipidomics of Hyperoxic Acute Lung Injury: Mass Spectrometric Characterization of Cardiolipin and Phosphatidylserine Peroxidation. Am. J. Physiol. 2010, 299, L73-L85.
20. Gharib, S. A.; Nguyen, E.; Altemeier, W. A.; Shaffer, S. A.; Doneanu, C. E.; Goodlett, D. R.; Schnapp, L. M. Of Mice and Men: Comparative Proteomics of Bronchoalveolar Fluid. Eur. Respir. J. 2010, 35, 1388-1395.
21. Guo, Y.; Ma, S. F.; Grigoryev, D.; Van Eyk, J.; Garcia, J. G. 1-DE MS and 2-D LC-MS Analysis of the Mouse Bronchoalveolar Lavage Proteome. Proteomics 2005, 5, 4608-4624.
22. Zhang, L.; Wang, M.; Kang, X.; Boontheung, P.; Li, N.; Nel, A. E.; Loo, J. A. Oxidative Stress and Asthma: Proteome Analysis of Chitinase-like Proteins and FIZZ1 in Lung Tissue and Bronchoalveolar Lavage Fluid. J. Proteome Res. 2009, 8, 1631-1638.
23. Shvedova, A. A.; Murray, A. R.; Johnson, V. J.; Gorelik, O.; Arepalli, S.; Hubbs, A. F.; Mercer, R. R.; Keohavong, P.; Sussman, N.; Jin, J.; et al. Inhalation vs. Aspiration of Single-Walled Carbon Nanotubes in C57BL/6 Mice: Inflammation, Fibrosis, Oxidative Stress and Mutagenesis. Am. J. Physiol. 2008, 295, L552-L565.
24. Mulugeta, S.; Meers, M. F. Surfactant Protein C; Its Unique Properties and Emerging Immunomodulatory Role in the Lung. Microbes Infect. 2006, 8, 2317-2323.
25. Park, W. Y.; Goodman, R. B.; Steinberg, K. P.; Ruzinski, J. T.; Radella, F.; Park, D. R.; Pugin, J.; Skerrett, S. J.; Hudson, L. D.; Martin, T. R. Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med. 2001, 164, 1896-1903.
26. Creuwels, L. A. J. M.; van Golde, L. M. G.; Haagsman, H. P. The Pulmonary Surfactant System: Biochemical and Clinical Aspects. Lung 1997, 175, 1-39.
27. Curstedt, T.; Johansson, J.; Persson, P.; Eklund, A.; Robertson, B.; Lowenadler, B.; Jornvall, H. Hydrophobic Surfactant-Associated Polypeptides: SP-C Is a Lipopeptide with Two Palmitoylated Cysteine Residues, Whereas SP-B Lacks Covalently Linked Fatty Acyl Groups. Proc. Natl. Acad. Sci. U. S. A. 1990, 87, 2985-2989.
28. Coonrod, J. D.; Jarrells, M. C.; Yoneda, K. Effect of Rat Surfactant Lipids on Complement and Fc Receptors of Macrophages. Infect. Immun. 1986, 54, 371-378.
29. Hamm, H.; Fabel, H.; Bartsch, W. The Surfactant System of the Adult Lung: Physiology and Clinical Perspectives. Clin. Invest. 1992, 70, 637-657.
30. Schürch, S.; Bachofenb, H.; Possmayer, F. Pulmonary Surfactant: Surface Properties and Function of Alveolar and Airway Surfactant. Pure Appl. Chem. 1992, 64, 1745-1750.
31. Trott, O.; Olson, A. J. AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. J. Comput. Chem. 2010, 31, 455-461.
32. Wang, H.; Michielssens, S.; Moors, S.; Ceulemans, A. Molecular Dynamics Study of Dipalmitoylphosphatidylcholine Lipid Layer Self-Assembly onto a Single-Walled Carbon Nanotube. Nano Res. 2009, 2, 945-954.
33. Wallace, E. J.; Sansom, M. S. Carbon Nanotube/Detergent Interactions via Coarse-Grained Molecular Dynamics. Nano Lett. 2007, 7, 1923-1928.
34. Greenberg, M. E.; Sun, M.; Zhang, R.; Febbraio, M.; Silverstein, R.; Hazen, S. L. Oxidized Phosphatidylserine-CD36 Interactions Play an Essential Role in Macrophage-Dependent Phagocytosis of Apoptotic Cells. J. Exp. Med. 2006, 203, 2613-2625.
35. Santiago, C.; Ballesteros, A.; Martinez-Munoz, L.; Mellado, M.; Kaplan, G. G.; Freeman, G. J.; Casasnovas, J. M. Structures of T Cell Immunoglobulin Mucin Protein 4 Show a Metal-Ion-Dependent Ligand Binding Site Where Phosphatidylserine Binds. Immunity 2007, 27, 941-951.
36. Kagan, V. E.; Konduru, N. V.; Feng, W.; Allen, B. L.; Conroy, J.; Volkov, Y.; Vlasova, I. I.; Belikova, N. A.; Yanamala, N.; Kapralov, A.; et al. Carbon Nanotubes Degraded by Neutrophil Myeloperoxidase Induce Less Pulmonary Inflammation. Nat. Nanotechnol. 2010, 5, 354-359.
37. Shvedova, A. A.; Kapralov, A. A.; Feng, W.; Kisin, E. R.; Murray, A.; Mercer, R.; St. Croix, C.; Lang, M.; Watkins, S.; Konduru, N.; et al. Impaired Clearance and Enhanced Pulmonary Inflammatory/Fibrotic Response to Carbon Nanotubes in Myeloperoxidase-Deficient Mice. PLoS One 2012, 10.1371/journal. pone.0030923.
38. Walczyk, D.; Bombelli, F. B.; Monopoli, M. P.; Lynch, I.; Dawson, K. A. What the Cell "Sees" in Bionanoscience. J. Am. Chem. Soc. 2010, 132, 5761-5768.
39. Lundqvist, M.; Stigler, J.; Cedervall, T.; Berggard, T.; Flanagan, M. B.; Lynch, I.; Elia, G.; Dawson, K. The Evolution of the Protein Corona around Nanoparticles: A Test Study. ACS Nano 2011, 5, 7503-7509.
40. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bombelli, F. B.; Dawson, K. A. Physical-Chemical Aspects of Protein Corona: Relevance to In Vitro and In Vivo Biological Impacts of Nanoparticles. J. Am. Chem. Soc. 2011, 133, 2525-2534.
41. Sund, J.; Alenius, H.; Vippola, M.; Savolainen, K.; Puustinen, A. Proteomic Characterization of Engineered Nanomaterial-Protein Interactions in Relation to Surface Reactivity. ACS Nano 2011, 5, 4300-4309.
42. Simberg, D.; Park, J. H.; Karmali, P. P.; Zhang, W. M.; Merkulov, S.; McCrae, K.; Bhatia, S. N.; Sailor, M.; Ruoslahti, E. Differential Proteomics Analysis of the Surface Heterogeneity of Dextran Iron Oxide Nanoparticles and the Implications for Their In Vivo Clearance. Biomaterials 2009, 30, 3926-3933.
43. Scott, C. D.; Povitsky, A.; Dateo, C.; Gokcen, T.; Willis, P. A.; Smalley, R. E. Iron Catalyst Chemistry in Modeling a High-Pressure Carbon Monoxide Nanotube Reactor. J. Nanosci. Nanotechnol. 2003, 3, 63-73.
44. Gorelik, O. N.; Arepalli, S. Purification Procedures for Single-Wall Carbon Nanotubes. NASA contractor report, NASA/CR-2000-208926, 2000.
45. Vallhov, H.; Qin, J.; Johansson, S. M.; Ahlborg, N.; Muhammed, M. A.; Scheynius, A.; Gabrielsson, S. The Importance of an Endotoxin-Free Environment during the Production of Nanoparticles Used in Medical Applications. Nano Lett. 2006, 6, 1682-1686.
46. Liu, J.; Rinzler, A. G.; Dai, H.; Hafner, J. H.; Bradley, R. K.; Boul, P. J.; Lu, A.; Iverson, T.; Shelimov, K.; Huffman, C. B.; et al. Fullerene Pipes. Science 1998, 280, 1253-1256.
47. Rao, G. V.; Tinkle, S.; Weissman, D. N.; Antonini, J. M.; Kashon, M. L.; Salmen, R.; Battelli, L. A.; Willard, P. A.; Hoover, M. D.; Hubbs, A. F. Efficacy of a Technique for Exposing the Mouse Lung to Particles Aspirated from the Pharynx. J. Toxicol. Environ. Health A 2003, 66, 1441-1452.
48. Folch, J.; Lees, M.; Sloane Stanley, G. H. A Simple Method for the Isolation and Purification of Total Lipides from Animal Tissues. J. Biol. Chem. 1957, 226, 497-509.